US Stock MarketDetailed Quotes
GMRE Global Medical REIT Inc
- 9.275
- -0.015-0.16%
Trading Jun 3 13:33 ET
608.33MMarket Cap40.33P/E (TTM)
9.380High9.240Low192.11KVolume9.380Open9.290Pre Close1.78MTurnover0.31%Turnover Ratio40.33P/E (Static)65.59MShares11.19052wk High1.22P/B573.28MFloat Cap7.98052wk Low0.84Dividend TTM61.81MShs Float224.084Historical High9.06%Div YieldTTM1.51%Amplitude1.260Historical Low9.283Avg Price1Lot Size
Global Medical REIT Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.37%14.29M | -10.58%68.44M | -1.00%18.13M | -9.00%16.67M | -23.87%17.88M | -4.05%15.77M | 10.98%76.54M | 5.93%18.31M | -1.58%18.31M | 32.01%23.48M |
| Net income from continuing operations | 6.49%2.31M | 8.69%21.73M | -70.18%551K | -51.81%4.83M | 269.87%14.18M | -49.30%2.17M | 9.02%20M | -66.32%1.85M | 86.83%10.03M | -7.95%3.83M |
| Operating gains losses | ---- | -117.56%-14.69M | --868K | ---2.29M | ---12.79M | ---485K | -531.71%-6.75M | --0 | ---- | ---- |
| Depreciation and amortization | -6.14%14.23M | 2.34%59.01M | -6.16%14.42M | -1.65%14.37M | 5.11%15.06M | 13.49%15.16M | 21.89%57.66M | 19.71%15.36M | 20.85%14.61M | 24.71%14.33M |
| Other non cash items | 24.19%765K | 10.84%2.99M | 10.12%751K | 11.76%836K | 38.10%783K | -11.62%616K | 21.79%2.69M | 16.98%682K | 26.14%748K | -1.73%567K |
| Change In working capital | -78.48%-4.25M | -227.26%-5.69M | 17.67%-536K | -66.69%-2.27M | -114.55%-504K | 25.42%-2.38M | 54.46%-1.74M | 68.64%-651K | -98.40%-1.36M | 7,432.61%3.47M |
| -Change in receivables | -253.76%-981K | 114.34%426K | 94.75%-87K | 87.76%-146K | -92.71%21K | 256.76%638K | -352.05%-2.97M | -35.13%-1.66M | -397.08%-1.19M | -63.95%288K |
| -Change in prepaid assets | 189.00%688K | -292.51%-1.77M | -494.74%-225K | -400.00%-300K | -169.04%-475K | -1,117.11%-773K | 360.50%921K | 195.00%57K | -53.49%100K | 3,722.22%688K |
| -Change in payables and accrued expense | -68.19%-2.06M | -149.79%-2.02M | -332.21%-1.17M | -126.61%-516K | -66.65%884K | -18.74%-1.22M | 111.17%4.06M | 148.74%503K | -7.40%1.94M | 130.72%2.65M |
| -Change in other working capital | -85.70%-1.9M | 38.16%-2.32M | 111.19%944K | 40.70%-1.31M | -476.54%-934K | 44.18%-1.02M | 29.00%-3.75M | 83.95%447K | 19.85%-2.21M | 91.56%-162K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.37%14.29M | -10.58%68.44M | -1.00%18.13M | -9.00%16.67M | -23.87%17.88M | -4.05%15.77M | 10.98%76.54M | 5.93%18.31M | -1.58%18.31M | 32.01%23.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -187.84%-2.72M | 149.26%67.62M | -120.85%-3.11M | 116.93%5.66M | 181.76%61.97M | 111.63%3.09M | 29.49%-137.25M | 94.95%-1.41M | 34.12%-33.45M | -4.69%-75.8M |
| Capital expenditure reported | -147.71%-2M | -82.10%-9.6M | -137.49%-3.83M | -59.94%-3.45M | -59.92%-1.52M | -45.50%-809K | 43.92%-5.27M | 79.31%-1.61M | -541.07%-2.15M | -7.44%-953K |
| Net PPE purchase and sale | ---- | 99.71%-442K | --0 | --0 | ---- | ---- | 21.50%-150.93M | 98.74%-335K | -0.95%-50.68M | -4.50%-75.45M |
| Net other investing changes | -159.85%-712K | -218.58%-1.26M | -151.87%-278K | -127.95%-417K | -147.68%-288K | 82.57%-274K | -30.08%1.06M | -39.98%536K | 734.89%1.49M | -11.82%604K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -187.84%-2.72M | 149.26%67.62M | -120.85%-3.11M | 116.93%5.66M | 181.76%61.97M | 111.63%3.09M | 29.49%-137.25M | 94.95%-1.41M | 34.12%-33.45M | -4.69%-75.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 45.73%-10.5M | -330.40%-143.79M | 0.87%-15.9M | -268.65%-24.5M | -244.10%-84.05M | -445.86%-19.34M | -51.13%62.41M | -239.07%-16.04M | -54.11%14.53M | 4.94%58.33M |
| Net issuance payments of debt | 334.67%5.97M | -170.60%-86.09M | -1,194.13%-7.82M | -123.57%-8.08M | -192.49%-67.64M | -118.41%-2.54M | 1,250.07%121.94M | -95.70%715K | -27.55%34.28M | 167.44%73.13M |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | -95.18%9.9M | -100.75%-83K | --0 | -96.47%1.77M |
| Cash dividends paid | -1.53%-16.4M | -0.94%-64.85M | -1.10%-16.27M | -1.10%-16.28M | -0.49%-16.14M | -1.08%-16.15M | -10.15%-64.24M | -4.41%-16.1M | -4.40%-16.1M | -9.17%-16.07M |
| Net other financing activities | 89.98%-64K | 237.73%7.15M | 1,530.72%8.2M | 95.92%-149K | 48.23%-263K | -40.13%-639K | 41.65%-5.19M | 25.39%-573K | -1,606.54%-3.65M | 92.94%-508K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 45.73%-10.5M | -330.40%-143.79M | 0.87%-15.9M | -268.65%-24.5M | -244.10%-84.05M | -445.86%-19.34M | -51.13%62.41M | -239.07%-16.04M | -54.11%14.53M | 4.94%58.33M |
| Net cash flow | ||||||||||
| Beginning cash position | -53.48%6.72M | 13.29%14.46M | -44.01%7.61M | -31.09%9.79M | 70.71%13.98M | 13.29%14.46M | 18.66%12.76M | 14.54%13.6M | 14.79%14.2M | -28.16%8.19M |
| Current changes in cash | 328.27%1.08M | -555.84%-7.73M | -203.26%-888K | -259.17%-2.17M | -169.82%-4.2M | 89.63%-474K | -15.45%1.7M | -3.37%860K | -20.76%-605K | 519.59%6.01M |
| End cash Position | -44.17%7.81M | -53.48%6.72M | -53.48%6.72M | -44.01%7.61M | -31.09%9.79M | 70.71%13.98M | 13.29%14.46M | 13.29%14.46M | 14.54%13.6M | 14.79%14.2M |
| Free cash flow | -17.87%12.29M | 173.30%58.39M | -12.61%14.3M | 138.31%13.22M | 130.07%15.91M | 274.22%14.96M | 39.97%-79.66M | 196.17%16.36M | -8.11%-34.52M | 4.30%-52.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg